Closing the Mortality Gap in Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: Implications of a Clinical Decision Support App

Diabetes is a major public health issue affecting millions of people in the United States and worldwide. In the United States alone, about 30.3 million people (9.4% of the population) have diabetes [1]. Worldwide, a staggering 422 million have diabetes according to 2014 estimates [2]. Diabetes complications over years of exposure include cardiovascular disease -- stroke and myocardial infarction -- and microvascular disorders -- kidney failure, blindness and amputation [3]. Acute and potentially fatal complications of diabetes include hyperglycemic crises, specifically diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) [4].